Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
Submitted by
admin
on September 14, 2023 - 11:11am
Source:
CNBC
News Tags:
Moderna Therapeutics
vaccines
Flu
flu vaccines
clinical trials
Headline:
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
snippet:
Moderna said its experimental mRNA-based flu vaccine generated a stronger immune response against four strains of the virus than a currently available flu vaccine.
The late-stage trial results cleared the way for a path to approval in the U.S.
Do Not Allow Advertisers to Use My Personal information
